Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers
Clinical trial NCT04220073 · COMPLETED
Trial details
- NCT number
- NCT04220073
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-17
- Primary completion
- 2020-11-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.